Associate Professor Borislava Mihaylova
- Health Economics Research Centre
Borislava (Boby) Mihaylova is an Associate Professor and Senior Health Economist at the Health Economics Research Centre at the University of Oxford. Her research programme focuses on economic aspects of chronic disease (such as cardiovascular, chronic kidney disease and diabetes) and comprises studies of the impact of disease events and interventions on morbidity, mortality, health-related quality of life and healthcare costs; development of disease models to evaluate long-term effects of disease and interventions, cost-effectiveness analyses of healthcare interventions and studies of socio-economic determinants of health. She is leading the development of the economic analyses in a number of large randomised controlled trials (SHARP, THRIVE, REVEAL and ACST-2) and in the individual participant data meta-analysis of statin trials (Cholesterol Treatment Collaboration). Her work on effectiveness and cost-effectiveness of statins for cardiovascular disease prevention in the Heart Protection Study and the Cholesterol Treatment Collaboration has been influential in informing treatment recommendations for people at different vascular disease risk.
Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery.
Edwards MR. et al, (2019), BMJ Open, 9
Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate.
Castellani J. et al, (2018), Malar J, 17
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Non-cardiovascular Diseases: a Meta-analysis
Herrington W. et al, (2018), Journal of the American Society of Nephrology
An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded RCT recruitment.
Jepson M. et al, (2018), Journal of clinical epidemiology
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time.
Lokuge K. et al, (2018), British Journal of Surgery, 105, 26 - 36